4SC: Landmark RESMAIN study data presented at the 5th World Congress of Cutaneous Lymphomas
Resminostat (Kinselby) as a maintenance therapy is now clinically proven to postpone disease progression in advanced Cut…
Resminostat (Kinselby) as a maintenance therapy is now clinically proven to postpone disease progression in advanced Cut…
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
Removes the requirement to conduct paediatric clinical studies when the development of the medicine is not needed or is…
MHH spin-off Cardior will be taken over for up to EUR 1.025 billion including an upfront payment and additional paym…
Entwicklungskandidat AB-1005 (AAV2-GDNF) von allen 11 Patienten über Zeitraum von 18 Monaten gut vertragen / Keine schwe…
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved…
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially a…
PELOBIOTECH GmbH is happy to announce organizing the first conference "Advancements in Animal-Free Research and Translat…
Analog Devices, Inc. (Nasdaq: ADI) recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the c…